In recent years, the non-medical use of prescription drugs (NMUPD) has caused
increasing public concern around the globe.
Women constitute a special risk category for NMUPD and understanding gender as it relates to this phenomenon is now a critical requirement for effective policy and practice. Intended primarily for policy makers and researchers, this Pompidou Group publication aims to explore gender specificities in terms of the use and misuse of prescription drugs in Europe and the Mediterranean region. Using secondary sources, it also seeks to identify gaps in the data available in the area covered and to make recommendations for further research, coherent policy development and effective, gender-sensitive practice.
This publication is an initial attempt to map this emerging phenomenon and to identify lacunae and avenues for further investigation. It constitutes an important resource for those interested in the interaction between gender and drug use.
LIST OF TABLES AND DIAGRAMS
AUTHOR AND CONTRIBUTORS
THE POMPIDOU GROUP ROLE IN INTEGRATING A GENDER DIMENSION OF DRUG POLICIES
Conceptual framework and a systematic review of the literature
Validation of submitted data and reporting
2. RESULTS AND DATA ANALYSIS
Part 1: Prescription-drug use and non-medical use of prescription drugs (NMUPD) in Europe and the Mediterranean region – A snapshot
Part 2: Data analysis
3. CONCLUSIONS AND RECOMMENDATIONS
Appendix 1: Survey
Appendix 2: Pompidou Group publications